Salmonella enteriditis infections in France and the United States : causes vs causal modelsHALLORAN, M. E.American journal of public health (1971). 1993, Vol 83, Num 12, pp 1167-1169, issn 0090-0036Article

Mycobacterium tuberculosis: just desserts for an ungrateful guestHALLORAN, M. E.Trends in ecology & evolution (Amsterdam). 1994, Vol 9, Num 2, pp 72-75, issn 0169-5347Article

Cheek rubbing as grooming by Abert squirrelsHALLORAN, M. E; BEKOFF, M.Animal behaviour. 1995, Vol 50, pp 987-993, issn 0003-3472, 4Article

Nesting behaviour of Abert squirrels (Sciurus aberti)HALLORAN, M. E; BEKOFF, M.Ethology. 1994, Vol 97, Num 3, pp 236-248, issn 0179-1613Article

Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boostingHALLORAN, M. E; STRUCHINER, C. J; SPIELMAN, A et al.Mathematical biosciences. 1989, Vol 94, Num 1, pp 115-149, issn 0025-5564Article

Randomization and baseline transmission in vaccine field trialsSTRUCHINER, C. J; HALLORAN, M. E.Epidemiology and infection. 2007, Vol 135, Num 2, pp 181-194, issn 0950-2688, 14 p.Article

Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacyDATTA, S; HALLORAN, M. E; LONGINI, I. M et al.Statistics in medicine. 1998, Vol 17, Num 2, pp 185-200, issn 0277-6715Article

A frailty mixture model for estimating vaccine efficacyLONGINI, I. M; HALLORAN, M. E.Applied statistics. 1996, Vol 45, Num 2, pp 165-173, issn 0035-9254Article

Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccinesLONGINI, I. M; DATTA, S; HALLORAN, M. E et al.Journal of acquired immune deficiency syndromes and human retrovirology. 1996, Vol 13, Num 5, pp 440-447, issn 1077-9450Article

Epidemiologic effects of vaccines with complex direct effects in an age-structured populationHALLORAN, M. E; WATELET, L; STRUCHINER, C. J et al.Mathematical biosciences. 1994, Vol 121, Num 2, pp 193-225, issn 0025-5564Article

Modeling malaria vaccines. I: New uses for old ideasSTRUCHINER, C. J; HALLORAN, M. E; SPIELMAN, A et al.Mathematical biosciences. 1989, Vol 94, Num 1, pp 87-113, issn 0025-5564Article

Interpretation and estimation of vaccine efficacy under heterogeneityHALLORAN, M. E; HABER, M; LONGINI, I. M et al.American journal of epidemiology. 1992, Vol 136, Num 3, pp 328-343, issn 0002-9262Article

Study designs for evaluating different efficacy and effectiveness aspects of vaccinesHALLORAN, M. E; STRUCHINER, C. J; LONGINI, I. M et al.American journal of epidemiology. 1997, Vol 146, Num 10, pp 789-803, issn 0002-9262Article

On individual and population effectiveness of vaccinationHABER, M; WATELET, L; HALLORAN, M. E et al.International journal of epidemiology. 1995, Vol 24, Num 6, pp 1249-1260, issn 0300-5771Article

On the distribution of vaccine protection under heterogeneous responseBRUNET, R. C; STRUCHINER, C. J; HALLORAN, M. E et al.Mathematical biosciences. 1993, Vol 116, Num 1, pp 111-125, issn 0025-5564Article

Semi-parametric models for mismeasured exposure information in vaccine trialsGOLM, G. T; HALLORAN, M. E; LONGINI, I. M et al.Statistics in medicine. 1998, Vol 17, Num 20, pp 2335-2352, issn 0277-6715Article

Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneityLONGINI, I. M; HALLORAN, M. E; HABER, M et al.Mathematical biosciences. 1993, Vol 117, Num 1-2, pp 271-281, issn 0025-5564Conference Paper

Comparison of two smoothing methods for exploring waning vaccine effectsDURHAM, L. K; HALLORAN, M. E; LONGINI, I. M et al.Applied statistics. 1999, Vol 48, Num 3, pp 395-407, issn 0035-9254Article

Estimation of vaccine efficacy in the presence of waning : Application to cholera vaccinesDURHAM, L. K; LONGINI, I. M; HALLORAN, M. E et al.American journal of epidemiology. 1998, Vol 147, Num 10, pp 948-959, issn 0002-9262Article

Predictors of Chlamydia trachomatis infection among female adolescents : A longitudinal analysisMOSURE, D. J; BERMAN, S; KLEINBAUM, D et al.American journal of epidemiology. 1996, Vol 144, Num 10, pp 997-1003, issn 0002-9262Article

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial : implications for influenza epidemic controlLONGINI, I. M; HALLORAN, M. E; NIZAM, A et al.Vaccine. 2000, Vol 18, Num 18, pp 1902-1909, issn 0264-410XArticle

A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccinesLONGINI, I. M; HUDGENS, M. G; HALLORAN, M. E et al.Statistics in medicine. 1999, Vol 18, Num 1, pp 53-68, issn 0277-6715Article

Testing for contributions of mitochondrial DNA mutations to complex diseasesFENGZHU SUN; ASHLEY-KOCH, A. E; DURHAM, L. K et al.Genetic epidemiology. 1998, Vol 15, Num 5, pp 451-469, issn 0741-0395Conference Paper

A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, MyanmarBERTOLLI, J; PANGI, C; FRERICHS, R et al.International journal of epidemiology. 1997, Vol 26, Num 4, pp 888-896, issn 0300-5771Article

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil : a case-control studyNORONHA, C. P; STRUCHINER, C. J; HALLORAN, M. E et al.International journal of epidemiology. 1995, Vol 24, Num 5, pp 1050-1057, issn 0300-5771Article